Compare Stocks → The Worst is Yet to Come… (From Porter & Company) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDigital Media StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:BLUCVE:FNRCVE:SVSNYSE:VTA Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLUBELLUS Health$14.74$14.62$6.38▼$14.76$1.87B0.193.08 million shs3.45 million shsFNR49 North ResourcesC$0.03-16.7%C$0.03C$0.02▼C$0.04C$4.16M0.86240,761 shs80,000 shsSVSSolarvest BioEnergyC$0.03C$0.02C$0.01▼C$0.14C$1.52M1.577,594 shs3,159 shsVTAInvesco Dynamic Credit Opportunities Fund$11.45$11.45$9.16▼$11.99N/AN/A295,911 shsN/A7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLUBELLUS Health0.00%0.00%0.00%0.00%+0.75%FNR49 North Resources-16.67%-28.57%-28.57%0.00%0.00%SVSSolarvest BioEnergy0.00%0.00%0.00%0.00%+25.00%VTAInvesco Dynamic Credit Opportunities Fund0.00%0.00%0.00%0.00%0.00%The only AI company to buy (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLUBELLUS HealthN/AN/AN/AN/AN/AN/AN/AN/AFNR49 North ResourcesN/AN/AN/AN/AN/AN/AN/AN/ASVSSolarvest BioEnergyN/AN/AN/AN/AN/AN/AN/AN/AVTAInvesco Dynamic Credit Opportunities FundN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLUBELLUS HealthN/AN/AN/AN/AFNR49 North ResourcesN/AN/AN/AN/ASVSSolarvest BioEnergyN/AN/AN/AN/AVTAInvesco Dynamic Credit Opportunities FundN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLUBELLUS Health$15K124,613.93N/AN/A$3.09 per share4.77FNR49 North ResourcesC$-1.44M-2.89C$0.06 per share0.45C$0.03 per share0.83SVSSolarvest BioEnergyC$740.002,052.70C$0.00 per share55.00C($0.10) per share-0.25VTAInvesco Dynamic Credit Opportunities FundN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLUBELLUS Health-$76.08M-$0.72N/AN/AN/A-578,586.63%-24.27%-23.14%N/AFNR49 North Resources-C$2.82M-C$0.02N/A∞N/AN/A-29.87%-8.02%8/29/2024 (Estimated)SVSSolarvest BioEnergy-C$2.26M-C$0.04N/A∞N/AN/AN/A-143.12%N/AVTAInvesco Dynamic Credit Opportunities FundN/AN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLUBELLUS HealthN/AN/AN/AN/AN/AFNR49 North ResourcesN/AN/AN/AN/AN/ASVSSolarvest BioEnergyN/AN/AN/AN/AN/AVTAInvesco Dynamic Credit Opportunities Fund$0.756.55%N/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLUBELLUS HealthN/A33.4233.42FNR49 North Resources77.280.891.26SVSSolarvest BioEnergyN/AN/A0.02VTAInvesco Dynamic Credit Opportunities FundN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLUBELLUS Health90.37%FNR49 North ResourcesN/ASVSSolarvest BioEnergyN/AVTAInvesco Dynamic Credit Opportunities FundN/AInsider OwnershipCompanyInsider OwnershipBLUBELLUS Health24.17%FNR49 North Resources8.31%SVSSolarvest BioEnergy15.85%VTAInvesco Dynamic Credit Opportunities FundN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableBLUBELLUS Health74126.81 million96.16 millionNot OptionableFNR49 North ResourcesN/A166.27 millionN/ANot OptionableSVSSolarvest BioEnergyN/A60.76 millionN/ANot OptionableVTAInvesco Dynamic Credit Opportunities FundN/AN/AN/ANot OptionableFNR, VTA, BLU, SVS, and KZG HeadlinesRecent News About These CompaniesMay 26, 2024 | finance.yahoo.comInvesco Dynamic Credit Opportunities Fund (XCRTX)April 30, 2024 | wsj.comInvesco Rochester Municipal Opportunities Fund;AFebruary 29, 2024 | wsj.comInvesco Fundamental Alternatives Fund;AFebruary 17, 2024 | livemint.comInvesco India Liquid Fund Direct Plan GrowthAugust 25, 2023 | benzinga.comInvesco Exchange-Traded Self-Indexed Fund Trust Invesco Russell 1000 Dynamic Multifactor ETF (BATS:OMFL), Quotes and News SummaryAugust 22, 2023 | seekingalpha.comXAXCX Invesco Dynamic Credit Opportunity Fund - Class AX AMay 11, 2023 | morningstar.comInvesco SteelPath MLP Select 40 R6April 25, 2023 | livemint.comInvesco India Short Term Fund Direct GrowthApril 20, 2023 | livemint.comInvesco India Liquid Fund Regular GrowthApril 1, 2023 | wsj.comInvesco Diversified Dividend Fund;InvestorFebruary 16, 2023 | livemint.comInvesco India Growth Opportunities Fund Direct Plan GrowthFebruary 11, 2023 | morningstar.comInvesco Value Opportunities CFebruary 10, 2023 | morningstar.comInvesco Value Opportunities R6February 8, 2023 | marketwatch.comInvesco President, CEO Marty Flanagan to Retire; Schlossberg to Take Helm >IVZJanuary 25, 2023 | morningstar.comInvesco Value Opportunities AJanuary 21, 2023 | morningstar.comInvesco Value Opportunities RJanuary 12, 2023 | morningstar.comInvesco Rochester® Municipal Opps ADecember 22, 2022 | msn.comInvesco DWA Financial Momentum ETF declares quarterly distribution of $0.1102September 29, 2022 | marketwatch.comInvesco Mortgage Capital Cuts Dividend; Shares DeclineAugust 22, 2022 | finextra.comAsset manager launches metaverse fundNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Value Stocks You Can Buy Before They Become BigMay 6, 2024 8:00 AMView 3 Value Stocks You Can Buy Before They Become Big3 Stocks Nancy Pelosi Has Been BuyingMay 10, 2024 8:35 AMView 3 Stocks Nancy Pelosi Has Been Buying3 Affordable Stocks That Won’t Stay Down Much LongerMay 13, 2024 9:12 AMView 3 Affordable Stocks That Won’t Stay Down Much Longer3 Reasons Nvidia is on The Verge of a 4 Digit Stock PriceMay 17, 2024 8:39 AMView 3 Reasons Nvidia is on The Verge of a 4 Digit Stock Price3 High-Yielding Oversold Stocks with Bullish RatingsMay 28, 2024 6:15 AMView 3 High-Yielding Oversold Stocks with Bullish RatingsAll HeadlinesCompany DescriptionsBELLUS HealthNASDAQ:BLUBELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.49 North ResourcesCVE:FNR49 North Resources Inc. is a venture capital firm specializing in seed capital and early stage investments. The firm typically invests in a diversified portfolio of common shares and other securities of resource issuers including all sectors of mineral exploration as well as oil and gas exploration and production around the globe. It focuses on resource issuers with exploration programs in Saskatchewan. The firm also seeks to co-invest. 49 North Resources Inc. was founded in 2005 and is based in Saskatoon, Canada.Solarvest BioEnergyCVE:SVSSolarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products. It provides human nutrition products, including omega-3; clean energy production system that enables for continuous hydrogen production; and active ingredients for human health comprising cannabinoids in algae and bone morphogenetic protein for the treatment of repairing bone fractures. Solarvest BioEnergy Inc. has a collaborative research and development agreement with FSD Pharma Inc. to produce cannabidiol (CBD), Cannabigerol (CBG), and tetrahydrocannabinol (THC) programs. The company was incorporated in 2005 and is based in Vancouver, Canada.Invesco Dynamic Credit Opportunities FundNYSE:VTAInvesco Dynamic Credit Opportunities Fund is a close-ended fixed income mutual fund launched by Invesco Ltd. The fund is co-managed by Invesco Advisers, Inc., Invesco Asset Management Deutschland GmbH, Invesco Asset Management Limited, Invesco Asset Management (Japan) Limited, Invesco Hong Kong Limited, Invesco Senior Secured Management, Inc., and Invesco Canada Ltd. It invests in the fixed income markets across the globe with a focus on the United States. The fund invests in securities of companies that operate across diversified sectors. It invests in fixed income securities such as senior secured floating rate loans, fixed rate loans, and collateralized debt. The fund employs fundamental analysis with a bottom-up security selection process to create its portfolio. It conducts in-house research to make its investments. The fund benchmarks the performance of its portfolio against the Credit Suisse Leveraged Loan Index. It was formerly known as Invesco Van Kampen Dynamic Credit Opportunities Fund. Invesco Dynamic Credit Opportunities Fund was formed on June 26, 2007 and is domiciled in the United States. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.